Manufacturing

Articles

CBM’s plasmid manufacturing offering is designed to provide phase-appropriate plasmids on demand for companies working on cell and gene therapies.

The Center for Breakthrough Medicines Announces Plasmid Manufacturing Service

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

In vivo CAR-T gene therapies could resolve challenges faced by autologous and allogeneic treatments.

Technology for In Vivo CAR T-cell Therapy Advances

Cheryl Barton is director of PharmaVision, 

TreeFrog Therapeutics is leaping ahead in cell therapies through 
resources such as new technologies and investor partnerships.


Frontrunners in the Latest Stem Cell Technology

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies

Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Com, discuss cell & gene therapies and co-processed APIs respectively.

AAPS 2022 Conference Highlights

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

Testing for Adventitious Agents in Viral Vector Production

Brian Mullan is the chief technical officer of Yposkesi, an SK Pharmteco company.

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

Choosing the Right CDMO for CGT Programs 

Cleo Bern Hartley is a pharma consultant, former pharma analyst, and research scientist.

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Growth in Cell and  Gene Therapy Market

Meg Rivers is the former senior editor for 

Podcasts

Experts from Umoja Biopharma dive into cell therapy development in this episode of the Drug Solutions Podcast, including the greatest advancements in cell therapy to date, areas for improvement, the biggest trends in cell therapy development, and retention as a pain point. 

Manufacturing, Cell Therapies